First Line Therapy: Is Imatinib still the best frontline treatment?

This debate is the first of 3 Regional Discussion Groups to be held in 2026. Here it is available in both the original English, and simultaneous translation to Spanish.

 

 

 

Experts:

In favour of the proposition:

Dr Katia Pagnano
Hematology & Hemotherapy Center
University of Campinas, Brasil

Professor Ehab Atallah
Hematologic Malignancies Division of Hematology & Oncology
Medical College of Wisconsin, USA

Against the proposition:

Dr Virginia Abello Polo
Center for Cancer Treatment and Research
Luis Carlos Sarmiento Angulo Foundation,
Bogotá, Colombia

Professor Giuseppe Saglio
Dept of Clinical and Biological Sciences
University of Turin
Turin, Italy

00:00 Welcome & Introductions

05:43 Dr Katia Pagnano: Imatinib is still the best frontline treatment.

16:03 Professor Ehab Atallah: Imatinib is still the best frontline treatment.

25:57 Dr Virginia Abello Polo: Imatinib is not the best frontline treatment.

35:51 Professor Giuseppe Saglio (presenting on behalf of Professor Timothy Hughes): Imatinib is not the best frontline treatment.

47:39 Question and answer session

01:21:54 Thanks and farewell